AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zovilda M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Retra Life Science Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Zovilda M 500mg/50mg Tablet

Combiflex DM 500mg/50mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications, such as nephropathy and vision impairment, and may lessen the risk of cardiovascular events like heart attacks and strokes. Combiflex DM 500mg/50mg tablets may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy is achieved through concurrent adherence to a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and other concurrent medications. Consuming the tablet with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Effective blood sugar regulation prevents future complications. Continued commitment to the prescribed diet and exercise regimen is crucial for overall diabetes management; lifestyle significantly impacts disease control. Common adverse effects include diarrhea, nausea, vomiting, dyspepsia, cephalalgia, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential side effect when used with insulin or sulfonylureas; proper recognition and management strategies are essential. This medication isn't universally suitable. Prior to commencing treatment, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic disorders, or excessive alcohol consumption. Pregnant or lactating women should seek medical counsel before use. Potential drug interactions exist; disclose all medications to your doctor to ensure treatment safety. Alcohol should be minimized due to its potential to lower blood glucose. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of Zovilda M 500mg/50mg Tablet

No information provided. Therefore, no text can be rewritten.

Uses of Zovilda M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Zovilda M 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Zovilda M 500mg/50mg tablets should be administered with a meal.

Common Side effects of Zovilda M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Zovilda M 500mg/50mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Zovilda M 500mg/50mg tablets should be administered with a meal.

How Zovilda M 500mg/50mg Tablet works:

Zovilda M, a 500mg/50mg tablet, combines two distinct anti-diabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Zovilda M 500mg/50mg Tablet with alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Zovilda M 500mg/50mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Zovilda M 500mg/50mg tablets while breastfeeding is likely inadvisable. Preliminary data from human studies indicate potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving may result from abnormally low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Caution is advised when administering Zovilda M 500mg/50mg Tablets to individuals with impaired renal function. Dosage modifications for Zovilda M 500mg/50mg Tablets may be necessary. Physician consultation is recommended.

LiverLiverUNSAFE

The use of Zovilda M 500mg/50mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical guidance is recommended.

What if you forget to take Zovilda M 500mg/50mg Tablet :

Should you forget a Zovilda M 500mg/50mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zovilda M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Zovilda M 500mg/50mg Tablet

Zovilda M 500mg/50mg Tablets rarely cause hypoglycemia (low blood sugar) by themselves. However, low blood sugar can occur if you don't consume enough calories while taking this medication. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more likely if you skip meals, drink alcohol, overexert yourself, or take other diabetes medication. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Zovilda M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) warrant immediate medical attention. Consult your doctor before taking any other medication.
Zovilda M 500mg/50mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Zovilda M 500mg/50mg tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Zovilda M 500mg/50mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in individuals with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Zovilda M 500mg/50mg Tablets and seek immediate medical attention.
Prolonged use of Zovilda M 500mg/50mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Zovilda M 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with proper use, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea). Report any persistent side effects to your physician.
Zovilda M 500mg/50mg Tabl...
171
MRP 198
13% off